The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Tatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 1,655.92 Crore) operating in Chemicals sector. Tatva Chintan Pharma Chem Ltd. key ...
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996. The status of the Company converted from Private Limited into a Public ...
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports.
While technology is sometimes a hit-or-miss affair, particularly with the intrusions of innovation occasionally outweighing its conveniences, the best pharmaceutical stocks typically enjoy ...
Pfizer is to acquire NextWave Pharmaceuticals, which specializes in the development and commercialization of unique products for the treatment of ADHD and related central nervous system disorders ...
When users buy LabVantage Pharma, they obtain full evidence of the validation process for the out-of-the-box platform. LabVantage Pharma leverages LabVantage 8 — a completely web-based ...
The Microsoft Surface Laptop is a powerful laptop that comes highly reviewed by Best Buy customers. It is favored for its high resolution and 14-inch screen. This build includes 16GB of RAM ...
The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...
Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...
Some of these drugs will never hit the shelf of pharmaceuticals even after countless clinical trials. On the other hand, if a biotech company gets a new drug sanctioned by the FDA and the demand ...
Healthcare & Pharmaceuticalscategory· March 21, 2025 Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results